Year |
Citation |
Score |
2019 |
Gao C, Schroeder JA, Xue F, Jing W, Cai Y, Scheck A, Subramaniam S, Rao S, Weiler H, Czechowicz A, Shi Q. Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A mice. Blood Advances. 3: 2700-2711. PMID 31515232 DOI: 10.1182/Bloodadvances.2019000516 |
0.642 |
|
2019 |
Czechowicz A, Palchaudhuri R, Scheck A, Hu Y, Hoggatt J, Saez B, Pang WW, Mansour MK, Tate TA, Chan YY, Walck E, Wernig G, Shizuru JA, Winau F, Scadden DT, et al. Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation. Nature Communications. 10: 617. PMID 30728354 DOI: 10.1038/S41467-018-08201-X |
0.677 |
|
2019 |
Li Z, Czechowicz A, Scheck A, Rossi DJ, Murphy PM. Hematopoietic chimerism and donor-specific skin allograft tolerance after non-genotoxic CD117 antibody-drug-conjugate conditioning in MHC-mismatched allotransplantation. Nature Communications. 10: 616. PMID 30728353 DOI: 10.1038/S41467-018-08202-W |
0.656 |
|
2018 |
Czechowicz A, Palchaudhuri R, Scheck A, Hu Y, Winau F, Hoggatt J, Saez B, Mansour MK, Sykes D, Scadden D, Rossi D. Immune Sparing Conditioning for BMT/HSCT Using Anti-Ckit Immunotoxins Biology of Blood and Marrow Transplantation. 24: S60-S61. DOI: 10.1016/J.Bbmt.2017.12.633 |
0.617 |
|
2016 |
Czechowicz A, Palchaudhuri R, Scheck A, Hoggatt J, Saez B, Scadden DT, Rossi DJ. Completely Non-Myeloablative/Non-Lymphoablative Conditioning for BMT/HSCT Using Anti-Ckit Immunotoxins Blood. 128: 493-493. DOI: 10.1182/Blood.V128.22.493.493 |
0.686 |
|
Show low-probability matches. |